Skip to main content

Featured

The Loonie Just Hit a 14-Month Low — Here's What It's Costing You

   Saturday, July 25, 2026 The Canadian dollar has slid to its weakest level since April 2025, and speculators are betting it has further to fall. Here's why it's happening and what it actually means for your wallet. If you've bought anything in U.S. dollars lately — a flight, an Amazon.com order, a hotel for a Florida trip — you may have noticed the exchange rate isn't doing you any favours. The Canadian dollar touched 1.4248 per U.S. dollar (about 70.2 U.S. cents ) last week, its weakest level in 14 months, before steadying closer to 1.41 . It's not just a bad week. Currency speculators have piled into bets against the loonie so aggressively that the Canadian dollar has overtaken the Japanese yen as the most heavily shorted major currency in the world, according to data from the U.S. Commodity Futures Trading Commission. Net short positions against the CAD hit roughly US$12.5 billion — the largest bearish bet on the loonie since December 2024. Why the loonie is ...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment